Solascure receives FDA Fast Track Designation for Aurase Wound Gel to treat calciphylaxis ulcers
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation…